𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus

✍ Scribed by Adela T. Casas-Melley; Kathleen P. Falkenstein; Louise M. Flynn; Valerie L. Ziegler; Stephen P. Dunn

Book ID
110895770
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
82 KB
Volume
8
Category
Article
ISSN
1397-3142

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of sirolimus in liver transplant rec
Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis
✍ Sumeet K. Asrani; Michael D. Leise; Colin P. West; M. Hassan Murad; Rachel A. Pe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 1 views

Sirolimus is used in patients with renal insufficiency after liver transplantation (LT) and especially in those with calcineurin inhibitor (CNI)-associated nephrotoxicity. We conducted a systematic review of all randomized controlled trials and observational studies to test the hypothesis that the u

Improvement of renal function after the
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction
✍ Javier F. CastroagudΓ­n; Esther Molina; Rafael Romero; Esteban Otero; Santiago To πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro